The 2016 Epilepsy Ireland National Conference is our largest ever member event spread across two days with twelve world class academics and medical experts.
Dr. David Goldstein - Director of the Institute for Genomic Medicine, Columbia University, New York
Dr. David Goldstein's research has focused on examining the relationship between human genetic variations and conditions such as epilepsy, hepatitis C, and schizophrenia, as well as the response of these diseases to pharmacologic treatment.
He went to Columbia from Duke University, where he has been director of the Center for Human Genome Variation and the Richard and Pat Johnson Distinguished University Professor, with appointments in the departments of molecular genetics & microbiology and biology.
Dr. Goldstein was elected a fellow of the American Association for the Advancement of Science in 2013 and received one of the first seven nationally awarded Royal Society/Wolfson research merit awards in the United Kingdom for his work in human population genetics.
Presentation topic: Dr. David Goldstein will be discussing Genomics – 'A New Era in Epilepsy Diagnosis and Treatment'.